| Website | celltrix.se |
| Category | BioTech |
| Phone | 46-40-29-12-13 |
| Employees |
| TOTAL | $3.85M |
| FUNDING TOTAL | $3.85M |
| Venture Round, 5/06 Novo A/S Seed Capital | €3M |
Celltrix is a Swedish biotechnology/medical device company focusing on reconstructive cosmetic surgery. Research, development and production are based in Malmö. They plan to launch the first product —Credurance — in 2010.
Their product represents a new type of dermal filler. An immediate filling effect is achieved and the surrounding cells are presented to a matrix suitable for cell growth. As the cells grow on and inside the matrix, they produce their own environment, natural collagen, which gradually replaces the matrix – biorestoring.
